ESC
↑↓ navigate   ↵ open
Site Search
Research Output

Publications

Over 25 peer-reviewed publications with 1,300+ citations and 500,000+ downloads. For the most up-to-date list, visit my Google Scholar profile.

Google Scholar → ResearchGate →
01
Achievements

Key Achievements

25+
Peer-reviewed publications
1,300+
Total citations
500K+
Paper downloads

First and corresponding author of a landmark Nature Neuroscience publication establishing a human in vitro model of Parkinson's disease. First author of the first paper demonstrating the cellular entry mechanism of SARS-CoV-2 (500+ citations).

02
Selected Works

Publications (Most Recent First)

2026
Neural cell state modulation by PARK2 and dopaminergic neuroprotection by small-molecule Parkin agonism
Gong Y, Bayati A, et al. — First Co-Author
Nature — Under Review
2026
Myeloid PINK1 represses mtDNA release and immune signaling that impacts neuronal pathology in patient-derived idiopathic PD models
Recinto SJ, MacDonald A, Premachandran S, Liu L, Bayati A, et al.
Manuscript, 2026
2025
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson’s disease (PPMI cohort)
Schumacher JG, Zhang X, Macklin EA, Wang J, Bayati A, et al.
PPMI Consortium, 2025
2025
AutoMorphoTrack: a modular Python framework for automated organelle morphology, motility, and colocalization analysis
Bayati A, Schumacher JG, Chen
bioRxiv 2025.07.19.665650
2024
Modeling Parkinson’s disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines
Bayati A, Ayoubi R, Aguila A, Zorca CE, Deyab G, Han C, Recinto SJ, et al. — First & Corresponding Author · 60+ citations
Nature Neuroscience 27:2401–2416 · PMID 39379564
2024
Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: mutations, propagation, aggregation, and formation of inclusions
Bayati A, McPherson PS · 35+ citations (invited review)
Invited review, 2024
2023
Visualization of α-synuclein trafficking via nanogold labeling and electron microscopy
Bayati A, Luo W, Del Cid-Pellitero E, Fon EA, Durcan TM, McPherson PS — First Author
STAR Protocols 4:102113 · PMID 36861831
2022
Rapid macropinocytic transfer of α-synuclein to lysosomes
Bayati A, Banks E, Han C, Luo W, Wolfgang WR, Zorca CE, Shlaifer I, et al. — First Author · 60+ citations
Cell Reports 40:111102 · PMID 35858558
2022
Host kinase CSNK2 is a target for inhibition of pathogenic SARS-like β-coronaviruses
Yang X, Dickmander RJ, Bayati A, et al. · 30+ citations
ACS Chemical Biology / JBC, 2022
2022
Identification and utilization of a chemical probe to interrogate PIKfyve in β-coronavirus lifecycle
Drewry DH, Potjewyd FM, Bayati A, et al. · 25+ citations
Journal of Medicinal Chemistry, 2022
2021
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis
Bayati A, Kumar R, Francis V, McPherson PS — First Author · 570+ citations
Journal of Biological Chemistry 296:100306 · PMID 33476648
2018
What are neurodegenerative diseases and how do they affect the brain?
Berman T, Bayati A · 55+ citations
Frontiers for Young Minds, 2018
2017
Localized versus systematic neurodegeneration: a paradigm for aetiological classification
Bayati A, Berman T · 15+ citations
Review, 2017

Additional manuscripts in preparation and under review, including work on Parkin agonism and telomerase activating compounds. The complete publication record is available on Google Scholar.

Live Publication Record

For the complete, dynamically updated list of all publications, citations, and h-index, visit my Google Scholar profile directly:

SCHOLAR Google Scholar — Full Publication List RG ResearchGate — Papers & Preprints ORCID ORCID Profile
Armin Bayati, PhD
Research Fellow · Harvard Medical School & Massachusetts General Hospital
Research
iPSC Models Neuroimmunology Cancer Immunology Drug Discovery Proteomics
Connect
Google Scholar LinkedIn GitHub ORCID
Contact
Reach Out to Armin Contact Page Publications
© 2026 Armin Bayati. All rights reserved.